David Lloyd

647 total citations
7 papers, 210 citations indexed

About

David Lloyd is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Lloyd has authored 7 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Lloyd's work include Genomics and Rare Diseases (2 papers), Cancer Genomics and Diagnostics (2 papers) and Stress Responses and Cortisol (1 paper). David Lloyd is often cited by papers focused on Genomics and Rare Diseases (2 papers), Cancer Genomics and Diagnostics (2 papers) and Stress Responses and Cortisol (1 paper). David Lloyd collaborates with scholars based in United Kingdom, United States and Switzerland. David Lloyd's co-authors include Lucila Ohno‐Machado, Jane C. Burns, Xiaoqian Jiang, Hai Yang, Kristin Lauter, Feng Chen, S. Cenk Şahinalp, Amalio Telenti, Shuang Wang and Eileen Png and has published in prestigious journals such as Bioinformatics, Journal of the American Medical Informatics Association and Diabetes Obesity and Metabolism.

In The Last Decade

David Lloyd

6 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Lloyd United Kingdom	5	102	58	49	43	42	7	210
Robert Reihs Austria	9	66 0.6×	68 1.2×	51 1.0×	15 0.3×	94 2.2×	21	248
Shang Xue China	5	53 0.5×	10 0.2×	31 0.6×	42 1.0×	48 1.1×	9	238
Michele E. Day United States	5	63 0.6×	29 0.5×	19 0.4×	9 0.2×	103 2.5×	5	195
Alexandros Sigaras United States	8	97 1.0×	234 4.0×	14 0.3×	16 0.4×	76 1.8×	16	523
Tyler Bath United States	6	29 0.3×	43 0.7×	18 0.4×	9 0.2×	84 2.0×	8	195
Michaela Th. Mayrhofer Netherlands	10	83 0.8×	139 2.4×	21 0.4×	36 0.8×	31 0.7×	28	325
Yingcheng Sun United States	9	96 0.9×	35 0.6×	13 0.3×	18 0.4×	50 1.2×	27	241
Suraj Rajendran United States	9	107 1.0×	49 0.8×	6 0.1×	10 0.2×	25 0.6×	18	235
Ana Cernea Spain	8	36 0.4×	16 0.3×	41 0.8×	25 0.6×	82 2.0×	25	273
Moustafa Abdalla United States	7	30 0.3×	22 0.4×	12 0.2×	26 0.6×	78 1.9×	18	200

Countries citing papers authored by David Lloyd

Since Specialization

Citations

This map shows the geographic impact of David Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lloyd more than expected).

Fields of papers citing papers by David Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lloyd. The network helps show where David Lloyd may publish in the future.

Co-authorship network of co-authors of David Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of David Lloyd. A scholar is included among the top collaborators of David Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Lloyd. David Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Siddiqui, Ruqaiyyah, David Lloyd, Sutherland K. Maciver, & Naveed Ahmed Khan. (2025). Gut microbiome-derived metabolites and epigenetic modulation as potential countermeasures to acute stress. Discover Medicine. 2(1).

2.

Curtin, François, Corinne Bernard, Sandrine Levet, et al.. (2018). A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti‐HERV‐W‐Env monoclonal antibody. Diabetes Obesity and Metabolism. 20(9). 2075–2084. 34 indexed citations

3.

Doan, Son, Cleo K. Maehara, Juan D. Chaparro, et al.. (2016). Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes. Academic Emergency Medicine. 23(5). 628–636. 39 indexed citations

4.

Raisaro, Jean Louis, Florian Tramèr, Zhanglong Ji, et al.. (2016). Addressing Beacon re-identification attacks: quantification and mitigation of privacy risks. Journal of the American Medical Informatics Association. 24(4). 799–805. 61 indexed citations

5.

Chen, Feng, Shuang Wang, Xiaoqian Jiang, et al.. (2016). PRINCESS: Privacy-protecting Rare disease International Network Collaboration via Encryption through Software guard extensionS. Bioinformatics. 33(6). 871–878. 70 indexed citations

6.

Lloyd, David, et al.. (2012). Hypophosphataemia as a cause of acute confusional state. BMJ Case Reports. 2012. bcr2012006960–bcr2012006960. 2 indexed citations

7.

Wang, Jenny, et al.. (2007). Kawasaki Disease: Four Case Reports of Cardiopathy with an Institutional and Literature Review. Pediatric and Developmental Pathology. 10(6). 491–499. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact